Robert Repella - Net Worth and Insider Trading
Robert Repella Net Worth
The estimated net worth of Robert Repella is at least $68,775 dollars as of 2024-09-20. Robert Repella is the SVP & Chief Commercial Officer of Vanda Pharmaceuticals Inc and owns about 15,000 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $68,775. Details can be seen in Robert Repella's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Repella has not made any transactions after 2013-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Repella
Robert Repella Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Repella owns 2 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and Vanda Pharmaceuticals Inc (VNDA) .
Click here to see the complete history of Robert Repella’s form 4 insider trades.
Insider Ownership Summary of Robert Repella
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2018-09-07 | director |
| VNDA | Vanda Pharmaceuticals Inc | 2013-11-21 | SVP & Chief Commercial Officer |
Robert Repella Latest Holdings Summary
Robert Repella currently owns a total of 1 stock. Robert Repella owns 15,000 shares of Vanda Pharmaceuticals Inc (VNDA) as of November 21, 2013, with a value of $68,775.
Latest Holdings of Robert Repella
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc | 2013-11-21 | 15,000 | 4.59 | 68,775 |
Holding Weightings of Robert Repella
Robert Repella Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Repella has made a total of 0 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 107,500 shares on November 21, 2013, which brought Robert Repella around $1 Million.
Insider Trading History of Robert Repella
- 1
Robert Repella Trading Performance
Robert Repella Ownership Network
Robert Repella Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Robert Repella is the director of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Robert Repella Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Repella. You might contact Robert Repella via mailing address: 1410 Parsons Lane, Ambler Pa 19002.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
